Literature DB >> 20498025

Feasibility of using tissue microarray cores of paraffin-embedded breast cancer tissue for measurement of gene expression: a proof-of-concept study.

Suzanne Drury1, Janine Salter, Frederick L Baehner, Steven Shak, Mitch Dowsett.   

Abstract

AIMS: To determine whether 0.6 mm cores of formalin-fixed paraffin-embedded (FFPE) tissue, as commonly used to construct immunohistochemical tissue microarrays, may be a valid alternative to tissue sections as source material for quantitative real-time PCR-based transcriptional profiling of breast cancer.
METHODS: Four matched 0.6 mm cores of invasive breast tumour and two 10 microm whole sections were taken from eight FFPE blocks. RNA was extracted and reverse transcribed, and TaqMan assays were performed on the 21 genes of the Oncotype DX Breast Cancer assay. Expression of the 16 recurrence-related genes was normalised to the set of five reference genes, and the recurrence score (RS) was calculated.
RESULTS: RNA yield was lower from 0.6 mm cores than from 10 microm whole sections, but was still more than sufficient to perform the assay. RS and single gene data from cores were highly comparable with those from whole sections (RS p=0.005). Greater variability was seen between cores than between sections.
CONCLUSIONS: FFPE sections are preferable to 0.6 mm cores for RNA profiling in order to maximise RNA yield and to allow for standard histopathological assessment. However, 0.6 mm cores are sufficient and would be appropriate to use for large cohort studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20498025     DOI: 10.1136/jcp.2010.075754

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  11 in total

1.  Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement.

Authors:  H A Azim; S Michiels; F Zagouri; S Delaloge; M Filipits; M Namer; P Neven; W F Symmans; A Thompson; F André; S Loi; C Swanton
Journal:  Ann Oncol       Date:  2013-01-20       Impact factor: 32.976

Review 2.  Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy.

Authors:  Wen Zhou; Joyce M Slingerland
Journal:  Nat Rev Cancer       Date:  2014-01       Impact factor: 60.716

3.  Prognostic significance of claudin expression changes in breast cancer with regional lymph node metastasis.

Authors:  A M Szasz; A M Tokes; M Micsinai; T Krenacs; Cs Jakab; L Lukacs; Zs Nemeth; Zs Baranyai; K Dede; L Madaras; J Kulka
Journal:  Clin Exp Metastasis       Date:  2010-10-21       Impact factor: 5.150

4.  In the era of genomics, should tumor size be reconsidered as a criterion for neoadjuvant chemotherapy?

Authors:  Xavier Pivot; Laura Mansi; Loic Chaigneau; Philippe Montcuquet; Antoine Thiery-Vuillemin; Fernando Bazan; Erion Dobi; Jean L Sautiere; Frederic Rigenbach; Marie P Algros; Steve Butler; Farid Jamshidian; Phillip Febbo; Christer Svedman; Sophie Paget-Bailly; Franck Bonnetain; Christian Villanueva
Journal:  Oncologist       Date:  2015-03-20

Review 5.  Genomic profiling in luminal breast cancer.

Authors:  Oleg Gluz; Daniel Hofmann; Rachel Würstlein; Cornelia Liedtke; Ulrike Nitz; Nadia Harbeck
Journal:  Breast Care (Basel)       Date:  2013-12       Impact factor: 2.860

6.  Intratumor Heterogeneity Affects Gene Expression Profile Test Prognostic Risk Stratification in Early Breast Cancer.

Authors:  Rekha Gyanchandani; Yan Lin; Hui-Min Lin; Kristine Cooper; Daniel P Normolle; Adam Brufsky; Michael Fastuca; Whitney Crosson; Steffi Oesterreich; Nancy E Davidson; Rohit Bhargava; David J Dabbs; Adrian V Lee
Journal:  Clin Cancer Res       Date:  2016-05-16       Impact factor: 12.531

7.  Is the 21-Gene Recurrence Score on Core Needle Biopsy Equivalent to Surgical Specimen in Early-Stage Breast Cancer? A Comparison of Gene Expression Between Paired Core Needle Biopsy and Surgical Specimens.

Authors:  Javier I J Orozco; Shu-Ching Chang; Diego M Marzese; Janie G Grumley; Chikako Matsuba; Miquel Ensenyat-Mendez; Gary L Grunkemeier
Journal:  Ann Surg Oncol       Date:  2021-07-09       Impact factor: 5.344

8.  Upregulation of Claudin-4, CAIX and GLUT-1 in distant breast cancer metastases.

Authors:  Laura S Jiwa; Paul J van Diest; Laurien D Hoefnagel; Jelle Wesseling; Pieter Wesseling; Cathy B Moelans
Journal:  BMC Cancer       Date:  2014-11-22       Impact factor: 4.430

9.  Addressing cellular heterogeneity in tumor and circulation for refined prognostication.

Authors:  Su Bin Lim; Trifanny Yeo; Wen Di Lee; Ali Asgar S Bhagat; Swee Jin Tan; Daniel Shao Weng Tan; Wan-Teck Lim; Chwee Teck Lim
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-15       Impact factor: 11.205

10.  A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.

Authors:  Lawrence J Solin; Robert Gray; Frederick L Baehner; Steven M Butler; Lorie L Hughes; Carl Yoshizawa; Diana B Cherbavaz; Steven Shak; David L Page; George W Sledge; Nancy E Davidson; James N Ingle; Edith A Perez; William C Wood; Joseph A Sparano; Sunil Badve
Journal:  J Natl Cancer Inst       Date:  2013-05-02       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.